Echuca COPD Workshop: Checking in with your patient's lungs

Overview

Chronic obstructive pulmonary disease (COPD) is the second leading cause of avoidable hospital admissions. With this in mind, the importance of engaging with patients around their symptoms and providing them with the knowledge, skills and confidence to manage their own lung health is essential. Early intervention and optimal management can reduce the rate of lung function decline and lead to better health outcomes for patients with COPD.

This half-day comprehensive workshop tailored to pharmacists will enhance your clinical understanding of COPD with focuses on non-pharmacotherapy interventions, COPD screening, COPD medications and inhaler devices and an emphasis on a pharmacist’s invaluable role in COPD detection and management.

Registration from 9.30am for a 10am start.

Lunch provided.

Practical components:

• COPD screening using Piko-6 Test device
• Inhaler devices: demonstration and hands-on practice
• Two comprehensive case studies

Participants will be provided with a demo kit containing placebo Inhaler devices and COPD resources to take home to support their pharmacy practice.

To prepare for this session and to maximize your learning, it is recommended that you undertake the pre-reading on COPDX Concise Guide for Primary Care by clicking here and on COPD-Asthma overlap paper by clicking here.

You may want to subscribe to the Lung Foundation Airwaves Clinical Update electronic newsletter by clicking here.

Cancellation policy: As places are limited, if you have registered but are unable to attend please email vic.branch@psa.org.au as a courtesy to other participants who may want the opportunity to attend. If the workshop is filled up and you are unable to register, please email vic.branch@psa.org.au to be placed on a waiting list.

Learning Objectives

After completing this activity, pharmacists should be able to:

• Describe the pathophysiology of COPD and how COPD is diagnosed.
• Explain to patients both the benefits of an action plan to reduce the impact of an acute exacerbation, and how to use an action plan.
• Describe the pharmacotherapy and non-pharmacotherapy management of COPD.
• Identify people at risk of COPD and undertake a test with a COPD screening device
• Describe the barriers and enablers to working with patients to optimise medicine management including inhaler device technique

*These learning objectives are correct at the time of publication and are subject to change.

Competency Standards (2016): 1.1.1, 1.1.2, 1.1.3, 1.4.1, 1.5.1, 2.1.1, 2.1.2, 2.1.3, 2.3.1, 2.3.2, 3.1.1, 3.1.2, 3.1.3, 3.2.2, 3.2.3, 3.2.5, 3.6.1, 3.6.2, 3.6.3

Competency Standards (2010): 1.2.1, 1.2.2, 1.3.1, 1.3.2, 2.1.1, 2.1.3, 4.2.1, 4.2.2, 4.2.3, 4.3.3, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.3, 6.3.1, 6.3.2, 6.3.3

*These competencies are correct at the time of publication and are subject to change.

CPD credits:

Accreditation number: CVP180006A

PSA is currently seeking accreditation for this activity. This activity may attract up to 3.5 hours of Group 2 CPD credits (or 7 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan.

*Please note: The above information is correct at time of publication and is subject to change

Speakers:

TBC

Sponsor

This education workshop is delivered in partnership with Lung Foundation Australia and funded by Murray PHN.